GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

0
Player Avatar plumbob13 (< 20) Submitted: 1/12/2011 4:09:38 PM : Outperform Start Price: $35.99 GSK Score: +20.33

under-priced, dividend is nice

Featured Broker Partners


Advertisement